Skip to content
10-K

Annual Report

Clearside Biomedical, Inc. CLSDQ

0000950170-25-046134

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 24, 2025 77.14M sh
Shares Diluted FY 2024 · Dec 31, 2024 73.8M sh
Shares Diluted FY 2024 · Dec 31, 2023 61.81M sh
Shares Diluted FY 2024 · Dec 31, 2022 60.2M sh
Capex FY 2024 · Dec 31, 2024 $977K
Capex FY 2024 · Dec 31, 2023 $1.78M
Capex FY 2024 · Dec 31, 2022 $246K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$24.7M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$18.14M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$13.37M
Cash And Equivalents FY 2024 · Dec 31, 2024 $20.02M
Cash And Equivalents FY 2024 · Dec 31, 2023 $28.92M
Cash And Equivalents FY 2024 · Dec 31, 2022 $48.26M
Stockholders Equity FY 2024 · Dec 31, 2024 −$38.86M
Stockholders Equity FY 2024 · Dec 31, 2023 −$15.91M
Stockholders Equity FY 2024 · Dec 31, 2022 $10.61M
Stockholders Equity FY 2024 · Dec 31, 2021 $37.98M
Current Liabilities FY 2024 · Dec 31, 2024 $4.79M
Current Liabilities FY 2024 · Dec 31, 2023 $6.81M
Total Liabilities FY 2024 · Dec 31, 2024 $63.98M
Total Liabilities FY 2024 · Dec 31, 2023 $49.93M
Current Assets FY 2024 · Dec 31, 2024 $21.27M
Current Assets FY 2024 · Dec 31, 2023 $30.12M
Total Assets FY 2024 · Dec 31, 2024 $25.13M
Total Assets FY 2024 · Dec 31, 2023 $34.02M
Eps Diluted FY 2024 · Dec 31, 2024 −$0.47
Eps Diluted FY 2024 · Dec 31, 2023 −$0.53
Eps Diluted FY 2024 · Dec 31, 2022 −$0.55
Eps Basic FY 2024 · Dec 31, 2024 −$0.47
Eps Basic FY 2024 · Dec 31, 2023 −$0.53
Eps Basic FY 2024 · Dec 31, 2022 −$0.55
Sga Expense FY 2024 · Dec 31, 2024 $11.81M
Sga Expense FY 2024 · Dec 31, 2023 $11.87M
Sga Expense FY 2024 · Dec 31, 2022 $11.77M
Rd Expense FY 2024 · Dec 31, 2024 $18.59M
Rd Expense FY 2024 · Dec 31, 2023 $20.85M
Rd Expense FY 2024 · Dec 31, 2022 $19.63M
Net Income FY 2024 · Dec 31, 2024 −$34.35M
Net Income FY 2024 · Dec 31, 2023 −$32.49M
Net Income FY 2024 · Dec 31, 2022 −$32.95M
Operating Income FY 2024 · Dec 31, 2024 −$28.88M
Operating Income FY 2024 · Dec 31, 2023 −$24.84M
Operating Income FY 2024 · Dec 31, 2022 −$30.28M
Cost Of Revenue FY 2024 · Dec 31, 2024 $149K
Cost Of Revenue FY 2024 · Dec 31, 2023 $355K
Cost Of Revenue FY 2024 · Dec 31, 2022 $204K
Revenue FY 2024 · Dec 31, 2024 $1.66M
Revenue FY 2024 · Dec 31, 2023 $8.23M
Revenue FY 2024 · Dec 31, 2022 $1.33M